Galaxy Surfactants Ltd
Galaxy Surfactants Ltd
ChemicalsKey Fundamentals
MicrocapSpecialty ChemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Galaxy Surfactants Ltd insights
49 extracted metrics + investor summaries across FY09–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 19.9%
Weaknesses
1- Company has a low return on equity of 12.9% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
Galaxy Surfactants Ltd is a nearly debt-free specialty chemicals company with a market cap of ₹7,361 Cr, trading at a PE of 27.2x. While TTM sales grew 24%, compounded profit has declined 9% TTM and ROE has trended down from 18% (10-year average) to 11% last year, reflecting margin pressures in the commodities segment.
- Company is almost debt free, providing strong balance sheet resilience and financial flexibility in a cyclical commodities business
- TTM sales growth of 24% indicates robust top-line momentum and demand recovery for surfactant products
- 10-year compounded sales CAGR of 11% demonstrates consistent long-term revenue growth trajectory
- 5-year compounded sales CAGR of 14% shows acceleration in medium-term revenue generation
- 10-year compounded profit CAGR of 10% reflects a historically profitable business model over longer cycles
- Price-to-book ratio of 2.65x is moderate for a specialty chemicals company with near-zero debt, suggesting assets are not excessively priced
- 10-year average ROE of 18% indicates the company has historically generated strong returns on shareholder equity
- Dividend yield of 1.07% provides some income return in a sector where many peers pay no dividends
- Compounded profit has declined 9% on a TTM basis and 10% over 3 years, indicating sustained earnings deterioration despite revenue growth
- ROE has fallen sharply from 18% (10-year average) to 11% last year, signaling weakening capital efficiency and margin compression
- Stock price CAGR of -21% over 1 year and -8% over 3 and 5 years shows persistent negative shareholder returns
- 3-year ROE average of only 13% compared to 10-year average of 18% indicates a structural decline in profitability rather than a one-off event
- PE of 27.2x appears elevated relative to declining earnings — profit compounding at -2% over 5 years does not support a growth multiple
- Dividend payout of only 10.2% of profits over last 3 years is low, limiting shareholder returns in a period of negative stock price performance
- 5-year compounded profit CAGR of -2% indicates the company has failed to grow earnings even over a medium-term horizon
- Widening gap between sales growth (6% 3-year CAGR) and profit growth (-10% 3-year CAGR) points to significant margin erosion from raw material or competitive pressures
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Chennai non-deal roadshow planned Jun 22
Galaxy Surfactants officials will attend a Non-Deal Roadshow in Chennai on June 25, 2026. Discussions will be based solely on publicly available information.
TL;DR: Limited recent news flow for Galaxy Surfactants with only a routine investor roadshow announced. No material headwinds or positive catalysts identified in the current news cycle. The absence of negative developments is mildly reassuring, but investors should watch for upcoming quarterly results and raw material cost trends for directional cues.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 942 | 983 | 940 | 929 | 974 | 1,063 | 1,042 | 1,145 | 1,278 | 1,326 | 1,329 | 1,315 | 1,782 |
| Expenses | 819 | 858 | 828 | 827 | 850 | 935 | 936 | 1,018 | 1,154 | 1,216 | 1,210 | 1,193 | 1,533 |
| Operating Profit | 123 | 125 | 112 | 102 | 124 | 128 | 106 | 127 | 124 | 110 | 119 | 122 | 249 |
| OPM % | 13% | 13% | 12% | 11% | 13% | 12% | 10% | 11% | 10% | 8% | 9% | 9% | 14% |
| Other Income | 2 | 3 | 6 | 24 | 5 | 9 | 4 | 8 | 11 | 6 | -7 | 0 | 3 |
| Interest | 6 | 5 | 6 | 5 | 4 | 4 | 5 | 6 | 7 | 7 | 9 | 8 | 9 |
| Depreciation | 24 | 25 | 25 | 26 | 27 | 28 | 28 | 28 | 29 | 30 | 31 | 33 | 36 |
| PBT | 96 | 98 | 88 | 94 | 99 | 104 | 77 | 100 | 99 | 79 | 73 | 80 | 207 |
| Tax % | 22% | 21% | 19% | 18% | 19% | 19% | 16% | 24% | 20% | 16% | 19% | 22% | 20% |
| Net Profit | 75 | 77 | 71 | 78 | 80 | 85 | 65 | 76 | 79 | 66 | 59 | 62 | 166 |
| EPS in Rs | 21.2 | 21.84 | 20.13 | 21.86 | 22.48 | 23.89 | 18.22 | 21.4 | 22.42 | 18.75 | 16.63 | 17.61 | 46.8 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,870 | 1,799 | 2,158 | 2,432 | 2,761 | 2,595 | 2,782 | 3,684 | 4,462 | 3,792 | 4,221 | 5,245 | 5,752 |
| Expenses | 1,681 | 1,563 | 1,886 | 2,144 | 2,408 | 2,226 | 2,334 | 3,284 | 3,894 | 3,330 | 3,737 | 4,778 | 5,152 |
| Operating Profit | 190 | 236 | 271 | 288 | 353 | 369 | 449 | 401 | 568 | 462 | 484 | 467 | 601 |
| OPM % | 10% | 13% | 13% | 12% | 13% | 14% | 16% | 11% | 13% | 12% | 11% | 9% | 10% |
| Other Income | 2 | 6 | 10 | 10 | 5 | 6 | 11 | 13 | 10 | 35 | 26 | 18 | 2 |
| Interest | 34 | 34 | 27 | 31 | 30 | 24 | 13 | 13 | 22 | 22 | 19 | 31 | 34 |
| Depreciation | 45 | 45 | 47 | 49 | 51 | 62 | 74 | 71 | 83 | 100 | 110 | 123 | 130 |
| PBT | 112 | 163 | 207 | 219 | 277 | 289 | 372 | 329 | 473 | 375 | 380 | 332 | 440 |
| Tax % | 40% | 37% | 29% | 28% | 31% | 20% | 19% | 20% | 19% | 20% | 20% | 19% | — |
| Net Profit | 67 | 103 | 148 | 158 | 191 | 230 | 302 | 263 | 381 | 301 | 305 | 267 | 354 |
| EPS in Rs | 19.03 | 28.97 | 41.64 | 44.57 | 53.87 | 64.99 | 85.22 | 74.12 | 107 | 85.03 | 86 | 75.41 | 99.79 |
| Div. Payout % | 21% | 31% | 14% | 16% | 15% | 22% | 21% | 24% | 20% | 26% | 5% | 29% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 |
| Reserves | 342 | 412 | 539 | 683 | 841 | 1,032 | 1,266 | 1,539 | 1,847 | 2,144 | 2,327 | 2,709 |
| Borrowings | 451 | 412 | 393 | 348 | 298 | 396 | 289 | 421 | 327 | 187 | 210 | 235 |
| Other Liabilities | 231 | 250 | 315 | 385 | 389 | 348 | 458 | 602 | 518 | 539 | 877 | 885 |
| Total Liabilities | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 | 3,865 |
| Fixed Assets | 459 | 436 | 456 | 447 | 519 | 748 | 712 | 760 | 923 | 973 | 1,030 | 1,174 |
| CWIP | 7 | 51 | 10 | 25 | 83 | 66 | 124 | 205 | 139 | 158 | 262 | 181 |
| Investments | 0 | 0 | 0 | 0 | 0 | 6 | 43 | 0 | 0 | 198 | 299 | 474 |
| Other Assets | 594 | 623 | 817 | 980 | 962 | 992 | 1,170 | 1,630 | 1,665 | 1,576 | 1,859 | 2,036 |
| Total Assets | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 | 3,865 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 41 | 170 | 111 | 145 | 283 | 316 | 365 | 5 | 573 | 518 | 421 | 333 |
| Investing | -26 | -59 | -43 | -54 | -166 | -149 | -166 | -82 | -141 | -341 | -290 | -366 |
| Financing | -17 | -110 | -57 | -90 | -119 | -144 | -165 | 59 | -264 | -189 | -157 | -51 |
| Net Cash Flow | -2 | 0 | 11 | 1 | -2 | 23 | 34 | -18 | 168 | -11 | -27 | -84 |
| Free Cash Flow | 15 | 116 | 68 | 89 | 115 | 174 | 258 | -150 | 429 | 362 | 205 | 198 |
| CFO/OP | 49 | 98 | 62 | 71 | 101 | 104 | 97 | 16 | 118 | 129 | 101 | 86 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 51 | 59 | 63 | 56 | 62 | 62 | 63 | 50 | 57 | 59 | 52 |
| Inventory Days | 68 | 72 | 79 | 75 | 68 | 72 | 91 | 103 | 78 | 82 | 95 | 76 |
| Days Payable | 50 | 59 | 63 | 71 | 59 | 60 | 80 | 75 | 52 | 66 | 81 | 62 |
| Cash Conversion Cycle | 61 | 64 | 75 | 67 | 65 | 73 | 72 | 91 | 76 | 73 | 73 | 66 |
| Working Capital Days | 4 | 27 | 31 | 39 | 41 | 43 | 50 | 63 | 55 | 64 | 52 | 47 |
| ROCE % | — | 23% | 26% | 25% | 28% | 24% | 25% | 19% | 24% | 17% | 16% | 14% |
Documents
Frequently Asked Questions about Galaxy Surfactants Ltd
What does Galaxy Surfactants Ltd do?
Where is Galaxy Surfactants Ltd (GALAXYSURF) listed?
Which sector does Galaxy Surfactants Ltd belong to?
What is the market capitalisation of Galaxy Surfactants Ltd?
What is the PE ratio of Galaxy Surfactants Ltd?
What is the 52-week high and low of Galaxy Surfactants Ltd?
Does Galaxy Surfactants Ltd pay dividends?
What is the Return on Equity (ROE) of Galaxy Surfactants Ltd?
How can I research Galaxy Surfactants Ltd on Tapetide?
Company Information
Galaxy Surfactants Ltd was Incorporated in 1986. It’s a leading manufacturer of Performance Surfactants and Specialty Care products with over 205 product grades. These products are used in consumer-centric Home and Personal care products like hair care, oral care, skin care, cosmetics, soap, shampoo, lotion, detergent, cleaning products, etc. Preferred suppliers to leading MNC’s, Regional and Local FMCG brands.[1] The company is India’s Largest Manufacturer of Oleo chemical-based Surfactants and Specialty Care Products for Home Care and Personal Care Industries [2]